Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: A comparative study

Toxicon

Volumn 53, Issue 6, 2009, Pages 602-608

  Casasola, Andrea ^a   Ramos Cerrillo, Blanca ^a   de Roodt, Adolfo R ^b   Saucedo, Alejandro Carbajal ^a   Chippaux, Jean Philippe ^c   Alagón, Alejandro ^a   Stock, Roberto P ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b Administracion Nacional   (Argentina)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

African cobras; Antiserum; Calculation methods; Neutralization; Paraspecificity

Indexed keywords

SNAKE VENOM; VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGENICITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DOSE CALCULATION; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; LD 50; LETHALITY; MOUSE; NAJA MELANOLEUCA; NEUROTOXICITY; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SNAKE; SPECIES DIFFERENCE; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVENINS; COBRA; COBRA VENOMS; HORSES; IMMUNE SERA; LETHAL DOSE 50; MICE; NEUTRALIZATION TESTS; REGRESSION ANALYSIS;

ELAPIDAE; EQUIDAE; NAJA; NAJA MELANOLEUCA; SERPENTES;

EID: 62649135137     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.01.011     Document Type: Article

References (37)

1. Borkow G., and Ovadia M. Selective lysis of virus-infected cells by cobra snake cytotoxins: a Sendai virus, human erythrocytes, and cytotoxin model. Biochem. Biophys. Res. Commun. 264 (1999) 63-68
2. 50: a critique. Biometrics 6 (1950) 413-423
3. Chen K.C., Kao P.H., Lin S.R., and Chang L.S. The mechanism of cytotoxicity by Naja naja atra cardiotoxin 3 is physically distant from its membrane-damaging effect. Toxicon 50 (2007) 816-824
4. Chiou Y.-L., Cheng Y.-C., Kao P.H., Wang J.J., and Chang L.S. Mutations on the N-terminal region abolish differentially the enzymatic activity, membrane-damaging activity and cytotoxicity of Taiwan cobra phospholipase A2. Toxicon 51 (2008) 270-279
5. Chippaux J.-P. Les serpents d'Afrique occidentale et centrale (2006), IRD Éditions, Paris pp. 224-228
6. Chippaux J.-P., Williams V., and White J. Snake venom variability: methods of study, results and interpretation. Toxicon 29 (1991) 1279-1303
7. Christensen P.A. South African Snake Venoms and Antivenoms (1955), South African Institute of Medical Research, Johannesburg Reprinted in Copenhagen, 1959
8. Feofanov A.V., Sharonov G.V., Astapova M.V., Rodionov D.I., Utkin Y.N., and Arseniev A.S. Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage. Biochem. J. 390 (2005) 11-18
9. Fry B.G., Vidal N., Norman J.A., Vonk F.J., Scheib H., Ramjan S.F.R., Kuruppu S., Fung K., Hedges S.B., Richardson M.K., Hodgson W.C., Ignjatovic V., Summerhayes R., and Kochva E. Early evolution of the venom system in lizards and snakes. Nature 439 (2006) 584-588
10. Fry B.G., Scheib H., Weerd L., Young B., McNaughtan J., Ramjan S.F.R., Vidal N., Poelmann R.E., and Norman J.A. Evolution of an arsenal. Structural and functional diversification of the venom system in the advanced snakes (Caenophidia). Mol. Cell Proteomics 7 (2008) 215-246
11. Hassan F., and El-Hawary M.F. Immunological properties of antivenins. II. Univalent Naja haje antivenin. Am. J. Trop. Med. Hyg. 25 (1976) 347-350
12. Hawgood B.J. Poul Agerholm Christensen MD (1912-1991): antivenom production at the South African Institute for medical research. Toxicon 39 (2001) 749-756
13. Khow O., Pakmanee N., Chanhome L., Sriprapat S., Omori-Satoh T., and Sitprija V. Cross-neutralization of Thai cobra (Naja kaouthia) and spitting cobra (Naja siamensis) venoms by Thai cobra antivenom. Toxicon 35 (1997) 1649-1651
14. Lin S.R., Chang L.S., and Chang K.L. Separation and structure-function studies of Taiwan cobra cardiotoxins. J. Protein Chem. 21 (2002) 81-86
15. Motulsky H. Intuitive Biostatistics (1995), Oxford University Press, USA
16. Motulsky H.J., and Ransnas L.A. Fitting curves to data using nonlinear regression: a practical and nonmathematical review. FASEB J. 1 (1987) 365-374
17. Mukherjee A.K. Phospholipase A2-interacting weak neurotoxins from venom of monocled cobra Naja kaouthia display cell-specific cytotoxicity. Toxicon 51 (2008) 1538-1543
18. Mukherjee A.K., and Maity C.R. The composition of Naja naja venom samples from three districts of West Bengal, India. Comp. Biochem. Physiol. 119A (1998) 621-627
19. Nkinin S.W., Chippaux J.-P., Piétin D., Doljansky Y., Trémeau O., and Ménez A. L'origine génétique de la variabilité des venins: impact sur la préparation des sérums antivenimeux. Bull. Soc. Pathol. Exot. 90 (1997) 277-281
20. 2+ changes in cultured single cells of rabbit aortic endothelium. Biochim. Biophys. Acta 1330 (1997) 29-38
21. ® Africa) against African vipers and elapids. Toxicon 52 (2008) 881-888
22. Raweerith R., and Ratanabanangkoon K. Immunochemical and biochemical comparisons of equine monovalent and polyvalent snake antivenoms. Toxicon 45 (2005) 369-375
23. 50 in quantal bioassay. Biometrics 43 (1987) 825-832
24. Seddik S.S., Wanas S., Helmy M.H., and Hashem M. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. J. Nat. Toxins 11 (2002) 329-335
25. Shashidharamurthy R., and Kemparaju K. Region-specific neutralization of Indian cobra (Naja naja) venom by polyclonal antibody raised against the eastern regional venom: a comparative study of the venoms from three different geographical distributions. Int. J. Immunopharmacol. 7 (2007) 61-69
26. Stevens-Truss R., and Hinman C.L. Chemical modification of methionines in a cobra venom cytotoxin differentiates between lytic and binding domains. Toxicol. Appl. Pharmacol. 139 (1996) 234-242
27. Stock R.P., Massougbodji A., Alagón A., and Chippaux J.-P. Bringing antivenoms to sub-Saharan Africa. Nat. Biotechnol. 25 (2007) 173-177
28. Theakston R.D.G., Warrell D.A., and Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41 (2003) 541-557
29. Trémeau O., Boulain J.-C., Couderc J., Fromageot P., and Ménez A. A monoclonal antibody which recognized the functional site of snake neurotoxins and which neutralizes all short-chain variants. FEBS Lett. 208 (1986) 236-240
30. Warrell D.A. Clinical toxicology of snakebite in Africa and the Middle East/Arabian peninsula. In: White J., and Meier J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press 433-492
31. Warrell D.A. Treatment of bites by adders and exotic venomous snakes. Br. Med. J. 331 (2005) 1244-1247
32. Warrell D.A. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product - 'what's in a name?'. Trans. R. Soc. Trop. Med Hyg 102 (2008) 397-399
33. World Health Organization. Progress in the Characterization of Venoms and Standardization of Antivenoms (1981), Offset Publication, WHO, Geneva
34. World Health Organization. Rabies and Envenomings: a Neglected Public Health Issue. Report of a Consultative Meeting (2007), WHO, Geneva
35. Wüster W., and Broadley D.G. A new species of spitting cobra (Naja) from north-eastern Africa (Serpentes: Elapidae). J. Zool. (Lond.) 259 (2007) 345-359
36. Wüster W., Crookes S., Ineich I., Mané Y., Pook C.E., Trape J.-F., and Broadley D.G. The phylogeny of cobras inferred from mitochondrial DNA sequences: evolution of venom spitting and the phylogeography of the African spitting cobras (Serpentes: Elapidae: Naja nigricollis complex). Mol. Phylogenet. Evol. 45 (2007) 437-453
37. Zhou H., Meng Q., Xie L., and Zhang R. A weak neurotoxin exhibits synergic effect with cardiotoxins when co-applied to two non-neural cell lines. Biol. Pharm. Bull. 27 (2004) 1241-1244